Neonatal Early Onset Sepsis Calculator
Estimates an individual newborn’s risk of early‑onset sepsis using maternal risk factors and the infant’s clinical condition to guide antibiotic decisions.
Indications for Use
Used for infants ≥34 weeks’ gestation with maternal EOS risk factors or clinical concerns to individualize sepsis risk and guide need for cultures, monitoring, or antibiotics. Reduces unnecessary antibiotic initiation by ~56% in meta‑analysis of 175 752 newborns 1 [Level I evidence] and by 19% absolute in a 2025 cluster‑RCT 2 [Level I evidence] without increased adverse events.
Insights & Cautions
Reduces empiric antibiotics by about half while maintaining similar safety to conventional strategies (meta-analysis of 175 752 newborns: RR 0.56 [95% CI 0.53–0.59] 1 [Level I evidence]).
Use cautiously because sensitivity is imperfect: 19%–31% of EOS cases may be initially missed vs NICE guidance 2 [Level II evidence], especially with chorioamnionitis.
Safe in RCTs but requires close clinical observation (cluster RCT; RR harm 0.48 [95% CI 0.36–0.63] 3 [Level I evidence]).